If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TRULICITY® (dulaglutide): Route of Administration
Trulicity (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm.
Trulicity® (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm. It must not be injected intravenously or intramuscularly (Trulicity Package Insert, 2017).
Enclosed Prescribing Information
TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly
The published reference below is available upon request by contacting 1-800-LillyRx.
Reference
Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2017.
Date of Last Review: January 17, 2017
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 8pm ET
